Unlisted
| Company Name | (주)디앤디파마텍 |
| English Name | D&D Pharmatech Inc. |
| Business Reg. No. | 1208821933 |
| CEO | 이슬기 |
| Address | 경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | Contact |
| Phone | 031-8019-7771 |
| Website | www.ddpharmatech.com |
| Regular Employees | 26persons |
| Corp. Reg. No. | 1101115575662 |
Venture Certified
| 벤처투자유형 | 2018-08-09 ~ 2020-08-08 | 20180300557 | 2018-08-09 |
| 벤처투자유형 | 2020-08-09 ~ 2022-08-08 | 20200300857 | 2018-08-09 |
| 벤처투자유형 | 2022-08-09 ~ 2025-08-08 | 20220803010009 | 2018-08-09 |
| 벤처투자유형 | 2025-08-09 ~ 2028-08-08 | 20250812010010 | 2018-08-09 |
Revenue CAGR +303.3%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 84B | 161B | 5.2B |
| Operating Profit | -102B | 33B | -158B |
| Net Profit | -75B | 111B | -2,402B |
| Total Assets | 1,269B | 950B | 980B |
| Total Liabilities | 60B | 51B | 493B |
| Total Equity | 1,209B | 899B | 487B |
Operating Loss: Op. profit -102B
Revenue down 48% YoY
▲ 0.8%
▼ 62.9%
▲ 92.0%
▼ 90.8%
▲ 97.4%
| Name | Position | Role |
|---|---|---|
| 이슬기 | 대표이사 | 대표 |
| NPS Subscribers | 26persons |
| CEO | 이슬기 |
| Est. Avg. Annual Salary | 6,35510K (53010K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +1persons |
| NPS Join Date | 2014-12-05 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기도 성남시 수정구 금토로80번길",
"brno": "120882****",
"cappedWarning": false,
"companyName": "(주)디앤디파마텍",
"estimatedAvgAnnualSalary": 63545388,
"estimatedAvgMonthlySalary": 5295449,
"fetchedAt": "2026-03-05T19:57:46.106Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20141205",
"last12MonthsHired": 1,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 1,
"leaveDate": null,
"monthlyPensionAmount": 13079760,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6750804",
"status": "1",
"styleCode": "1",
"subscriberCount": 26,
"turnoverMonths": 1
}{
"address": "경기 성남시",
"ceo_name": "이슬기",
"certificate": [
{
"cert_number": "20180300557",
"changes": "",
"disclosure_date": "2018-08-09",
"first_cert_date": "2018-08-09",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2018-08-09 ~ 2020-08-08"
},
{
"cert_number": "20200300857",
"changes": "",
"disclosure_date": "2020-07-30",
"first_cert_date": "2018-08-09",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2020-08-09 ~ 2022-08-08"
},
{
"cert_number": "20220803010009",
"changes": "",
"disclosure_date": "2022-08-03",
"first_cert_date": "2018-08-09",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-08-09 ~ 2025-08-08"
},
{
"cert_number": "20250812010010",
"changes": "",
"disclosure_date": "2025-08-12",
"first_cert_date": "2018-08-09",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-08-09 ~ 2028-08-08"
}
],
"company_name": "(주)디앤디파마텍",
"financials": {
"2022": {
"capital_stock": 4033584000,
"cost_of_sales": 0,
"current_assets": 20105439000,
"current_liabilities": 46470740000,
"gross_profit": 515108000,
"net_income": -240167339000,
"net_income_bs": -240167338000,
"non_current_assets": 77880148000,
"non_current_liabilities": 2848746000,
"non_operating_expenses": 240422287000,
"non_operating_income": 16061292000,
"operating_profit": -15806344000,
"revenue": 515108000,
"sga_expenses": 16321451000,
"total_assets": 97985587000,
"total_equity": 48666101000,
"total_liabilities": 49319486000
},
"2023": {
"capital_stock": 4649465000,
"cost_of_sales": 0,
"current_assets": 16091725000,
"current_liabilities": 3204501000,
"gross_profit": 16112110000,
"net_income": 11063901000,
"net_income_bs": 9150052000,
"non_current_assets": 78956105000,
"non_current_liabilities": 1941469000,
"non_operating_expenses": 9063482000,
"non_operating_income": 16834665000,
"operating_profit": 3292718000,
"revenue": 16112110000,
"sga_expenses": 12819391000,
"total_assets": 95047829000,
"total_equity": 89901859000,
"total_liabilities": 5145970000
},
"2024": {
"capital_stock": 5284035000,
"cost_of_sales": 0,
"current_assets": 34011665000,
"current_liabilities": 2631222000,
"gross_profit": 8378922000,
"net_income": -7491205000,
"net_income_bs": -7501363000,
"non_current_assets": 92854496000,
"non_current_liabilities": 3340023000,
"non_operating_expenses": 885175000,
"non_operating_income": 3583409000,
"operating_profit": -10189439000,
"revenue": 8378922000,
"sga_expenses": 18568361000,
"total_assets": 126866161000,
"total_equity": 120894916000,
"total_liabilities": 5971245000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2021-05-07"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2021-05-07"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2021-05-07"
},
{
"amount": "4,925,705,708",
"changes": "4,925,705,708",
"date": "2019-05-17"
},
{
"amount": "3,003,524,062",
"changes": "3,003,524,062",
"date": "2019-05-17"
},
{
"amount": "720,800,388",
"changes": "720,800,388",
"date": "2019-05-17"
},
{
"amount": "720,800,388",
"changes": "720,800,388",
"date": "2019-05-17"
},
{
"amount": "12,500,000,000",
"changes": "12,500,000,000",
"date": "2019-05-07"
},
{
"amount": "20,499,000,000",
"changes": "20,499,000,000",
"date": "2019-05-07"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2018-03-12"
},
{
"amount": "45,999,817,000",
"changes": "45,999,817,000",
"date": "2018-03-12"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2018-03-12"
}
],
"phone": "031-8019-****",
"source": "pg_migration"
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |